期刊： JOURNAL OF CHEMOTHERAPY, ; ()
Fatigue was a frequently reported adverse event associated with the use of PARP inhibitors. We performed a systematic review and meta-analysis to full......
期刊： JOURNAL OF CHEMOTHERAPY, ; ()
Clinical studies have reported that miRNAs abnormal expression are associated with the generation of cisplatin-resistant to osteosarcoma. Our previous......
期刊： JOURNAL OF CHEMOTHERAPY, ; ()
The objective of this study is to assess the effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma (STS) and provide......
期刊： JOURNAL OF CHEMOTHERAPY, ; ()
There is no standard treatment strategy for the third-line and above treatment of advanced nonsmall cell lung cancer (NSCLC). This study aimed to inve......
期刊： JOURNAL OF CHEMOTHERAPY, ; ()
Some colorectal cancer patients show resistance to conventional chemotherapeutic agents including Taxol. This study investigated the roles of lncRNA u......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (7)
The combating of multidrug resistance (MDR) plays a crucial role in effective chemotherapy. However, current strategies for cancer of MDR remain unsat......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (7)
This study aimed to investigate the efficacy of colistin both alone and in combination with either meropenem or levofloxacin against CRAB clinical iso......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (2)
Plants and natural compounds have been widely recognized to have potential for the prevention of cancer progression and as complementary or standalone......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (3)
Along with changes in dietary habits and lifestyle, the incidence of esophageal cancer is increasing around the world. Since chemotherapy for esophage......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (4)
Patients with metastatic colorectal cancer (mCRC) beyond second line treatment have a poor prognosis. Regorafenib, TAS-102, fruquintinib, panitumumab ......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (4)
Conventional anthracyclines represent a cornerstone drug in the treatment of breast cancer. Pegylated liposomal doxorubicin (PLD) has similar efficacy......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (8)
The role of chemotherapy in the treatment of myxofibrosarcoma is unclear. There are no randomized clinical trials evaluating the therapeutic effect of......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 33 (1)
Abnormal expression of ADAM29 has been frequently reported in several cancers, however, its role in clear cell renal cell carcinoma (ccRCC) has not ev......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (6)
In this study, we detected and measured the count of circulating tumour cells (CTCs) in breast cancer (BC) patients who were treated by neoadjuvant ch......
期刊： JOURNAL OF CHEMOTHERAPY, 2020; 32 (8)
Objective The objective of this study was to investigate the cumulative fraction of response (CFR) of various tigecycline dosing regimens in patients ......
